Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
What dose and fractionation do you utilize for node positive HCC?
Related Questions
How likely is late radiation induced lumbosacral plexopathy from treatment of anal cancer with chemo-RT 20 years ago and how would you manage it?
In a young patient with stage IIIB, low lying rectal cancer who is s/p 8 cycles of FOLFOX, do you prefer short or long course radiation prior to surgery?
What are your top takeaways from ASCO GI 2025?
Are the results of CONKO-007 changing practice for the management of pancreatic cancer?
What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?
In resected intrahepatic cholangiocarcinoma with an R0 margin <1 mm and perineural invasion, would you consider adjuvant RT in addition to capecitabine?
What are your institutions' preferences on SBRT vs. histotripsy for treatment of liver metastases?
Given that ESOPEC did not mandate PET staging, are the conclusions of the study still applicable for patients who are staged with PET?
How do you manage oxaliplatin-induced splenomegaly?
Which GI cancer patients do you use oral contrast in staging CT scans?
